ArticleJournal for immunotherapy of cancer2020

Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma.

Alison M Weppler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.